Skip to main content

What the FDA labels say about taking them together

Lanreotide and quinidine

Lanreotide's FDA label of October 11, 2024 names quinidine in its drug interactions section; the quinidine label PlainMeds reads does not name lanreotide. The lanreotide label: “Since it cannot be excluded that SOMATULINE DEPOT may have this effect, avoid other drugs mainly metabolized by CYP3A4 and which have a low therapeutic index.”

Check it at the source: the lanreotide FDA label on DailyMed (effective October 11, 2024, Ipsen Biopharmaceuticals, Inc.); the quinidine FDA label on DailyMed (effective February 1, 2018, Sun Pharmaceutical Industries, Inc.).

What does the lanreotide label say about quinidine?

Lanreotide label, drug interactions

Since it cannot be excluded that SOMATULINE DEPOT may have this effect, avoid other drugs mainly metabolized by CYP3A4 and which have a low therapeutic index (e.g., quinidine, terfenadine).

Source: FDA drug label (Lanreotide Acetate, NDA215395), Cipla USA Inc., effective September 1, 2024 (SPL set 11da176a-99bc-4ada-8b3f-6bd2b37a6313), via openFDA

Source: FDA drug label (SOMATULINE DEPOT), Ipsen Biopharmaceuticals, Inc., effective October 11, 2024 (SPL set 6e4a41fd-a753-4362-87ee-8cc56ed3660d), via openFDA; the full label on DailyMed

What does the quinidine label say about lanreotide?

Quinidine's label (effective February 1, 2018) does not name lanreotide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Quinidine Gluconate), Sun Pharmaceutical Industries, Inc., effective February 1, 2018 (SPL set 5023f053-fcc4-4c2c-aa59-9ec198ad185e), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

3Lanreotide generic labelers
4Quinidine generic labelers
LanreotideQuinidine
Labeled forn/aAtrial fibrillation
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$4.92 per tablet 324 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?